Pfizer to push for vaccine clearance in children 5 years old and over

The makers of the Pfizer-BioNTech vaccine will soon ask regulators for clearance its use in children 5 years and over, and are getting ready to make smaller doses of the vaccine for younger children, according to one of the founders of BioNTech, the German company that developed the vaccine in partnership with Pfizer.

“We will be presenting the results from our study on five- to 11-year-olds to authorities around the world in the coming weeks,” Ozlem Tureci, the co-founder of BioNTech and its chief medical officer, told Der Spiegel, a German news site, in an interview published on Friday. She added that the company would be applying for clearance of the use of the vaccine for that age group, including in Europe.

Pfizer and BioNTech will soon seek clearance for vaccine use in children 5 years and over. – The New York Times (nytimes.com)

Posted

in

by

Tags: